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Abstract
The respiratory mucosa is a major site for pathogen invasion and, hence, a site requiring
constant immune surveillance. The type I, semi-invariant natural killer T (NKT) cells are en-
riched within the lung vasculature. Despite optimal positioning, the role of NKT cells in respi-
ratory infectious diseases remains poorly understood. Hence, we assessed their function in
a murine model of pulmonary tularemia—because tularemia is a sepsis-like proinflamma-
tory disease and NKT cells are known to control the cellular and humoral responses under-
lying sepsis. Here we show for the first time that respiratory infection with Francisella
tularensis live vaccine strain resulted in rapid accumulation of NKT cells within the lung
interstitium. Activated NKT cells produced interferon-γ and promoted both local and system-
ic proinflammatory responses. Consistent with these results, NKT cell-deficient mice
showed reduced inflammatory cytokine and chemokine response yet they survived the in-
fection better than their wild type counterparts. Strikingly, NKT cell-deficient mice had in-
creased lymphocytic infiltration in the lungs that organized into tertiary lymphoid structures
resembling induced bronchus-associated lymphoid tissue (iBALT) at the peak of infection.
Thus, NKT cell activation by F. tularensis infection hampers iBALT formation and promotes
a systemic proinflammatory response, which exacerbates severe pulmonary tularemia-like
disease in mice.
Author Summary
NKT cells are innate-like lymphocytes with a demonstrated role in a wide range of diseases.
Often cited for their ability to rapidly produce a variety of cytokines upon activation, they
PLOS Pathogens | DOI:10.1371/journal.ppat.1004975 June 11, 2015 1 / 23
a11111
OPEN ACCESS
Citation: Hill TM, Gilchuk P, Cicek BB, Osina MA,
Boyd KL, Durrant DM, et al. (2015) Border Patrol
Gone Awry: Lung NKT Cell Activation by Francisella
tularensis Exacerbates Tularemia-Like Disease.
PLoS Pathog 11(6): e1004975. doi:10.1371/journal.
ppat.1004975
Editor: Padmini Salgame, New Jersey Medical
School, UNITED STATES
Received: January 29, 2015
Accepted: May 26, 2015
Published: June 11, 2015
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: Supported by a VA Merit Award
(BX001444) as well as Research Grants (AI042284,
HL121139, and AI097375), and Core Grants
(CA068485 and DK058404). TMH is supported by
the US Army. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: All authors have declared that
no competing interests exist.
have long been appreciated for their ability to “jump-start” the immune system and to
shape the quality of both the innate and adaptive response. This understanding of their
function has been deduced from in vitro experiments or through the in vivo administration
of highly potent, chemically synthesized lipid ligands, which may not necessarily reflect a
physiologically relevant response as observed in a natural infection. Using a mouse model
of pulmonary tularemia, we report that intranasal infection with the live vaccine strain of F.
tularensis rapidly activates NKT cells and promotes systemic inflammation, increased tissue
damage, and a dysregulated immune response resulting in increased morbidity and mortal-
ity in infected mice. Our data highlight the detrimental effects of NKT cell activation and
identify a potential new target for therapies against pulmonary tularemia.
Introduction
The respiratory mucosa is a major site for pathogen entry and hence, requires constant im-
mune surveillance. Like other mucosal surfaces, the lungs are populated by a variety of innate
cells and innate-like lymphocytes. One such cell type, the type I, semi-invariant natural killer T
(NKT) cells, are enriched within the lung vasculature where they are optimally positioned for
early antigen encounter [1]. These pulmonary NKT cells exert diverse functions dependent
upon experimental settings [2].
NKT cells express an invariant TCR α-chain (Vα14-Jα18 in mice and Vα24-Jα18 in hu-
mans) and one of a restricted set of TCR β-chains and, hence, called semi-invariant. Their
name also reflects their hybrid nature, in that they co-express markers of both NK cells and
conventional T cells. Their innate-like character is reflected in their ability to rapidly respond
to stimulation by producing a wide variety of cytokines [3]. Several subsets of NKT cells have
been identified, each of which may have distinct functional consequences in disease conditions
where NKT cells are known to play a role [3–7]. NKT cell functions are controlled by microbial
or self-glycolipids presented by CD1d molecules or by pro-inflammatory cytokines produced
by activated antigen presenting cells (APCs). The quality and magnitude of the NKT cell re-
sponse is determined by the mode of activation and the chemical nature of the activating lipid
(s) [4]. Activated NKT cells can stimulate APCs, natural killer cells, and other leukocytes
through the expression of cytokines and costimulatory molecules, thus functioning at the inter-
face between innate and adaptive immunity [4]. Consequently, NKT cells control microbial
and tumour immunity as well as autoimmune diseases [8–10].
In the lungs, NKT cells promote inflammation in models of airway hyperreactivity (AHR),
acute lung injury (ALI), and chronic obstructive pulmonary disease (COPD) [2]. NKT cells
may also contribute to the inflammatory cascade accompanying sepsis, which is often a com-
plication of bacterial infections of the lung [11,12]. In general, pulmonary NKT cells are
thought to play a protective role in microbial infections, but in some cases, may also exacerbate
disease [2]. However, the mechanisms by which pulmonary NKT cells contribute to disease pa-
thology remain poorly defined. The disparate results encountered in the literature are likely
due to the differential function of individual NKT cell subsets, the various means by which
NKT cells are activated in different disease settings, and the use of different NKT-deficient
mouse models [13,14].
To probe the function of lung NKT cells, we chose a respiratory Francisella tularensis infec-
tion model as this infection causes lethal pulmonary tularemia. F. tularensis is a gram-negative
facultative intracellular bacterium, which infects multiple cell types including macrophages,
dendritic cells, hepatocytes, neutrophils, and epithelial cells [15,16]. The resulting disease
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targets multiple organs and manifests itself in several forms of differing severity depending on
the inciting bacterial strain, dose, and route of infection. Of these, the respiratory route is the
most deadly, and the most likely route of infection by weaponized F. tularensis [17]. After inha-
lation, patients typically show signs of systemic illness, which may be accompanied by immedi-
ate signs of respiratory disease and can result in death in 30–60% of cases if left untreated [18–
21]. Although the exact cause of death is unclear, it is likely due to an overwhelming systemic
inflammatory response [22]. Mice inoculated intranasally (i.n.) with F. tularensis fail to mount
an effective immune response for the first 48–72h. After this initial immune latency, the re-
sponse to F. tularensis is characterized by a robust local and systemic “cytokine storm” reminis-
cent of sepsis [23,24]. Little is known about the role of NKT cells in pulmonary tularemia—in
either humans or mice, due in part to the difficulties in distinguishing them from NK cells,
which protect mice from tularemia-like disease-but a beneficial role has been implied [25].
Each of the cell types known to be susceptible to F. tularensis infection has been shown to acti-
vate NKT cells [4]. Therefore, we reasoned that NKT cells might be activated very early after
infection and could function in shaping the quality of both the innate and adaptive response.
The results emerging from testing the afore hypothesis revealed that indeed respiratory in-
fection with F. tularensis activated iNKT cells which produced interferon (IFN)-γ and propa-
gated a sepsis-like proinflammatory response that led to a lethal phenotype in wild type mice.
This proinflammatory response was much tempered in CD1d-deficient mice that lacked NKT
cells. Strikingly, however, the mutant mice had increased lymphocytic infiltration in the lungs
that organized into structures resembling induced bronchus-associated lymphoid tissue
(iBALT) at the peak of infection. Hence, NKT cell activation by F tularensis infection hampers
iBALT formation, which in conjunction with an NKT cell-dependent proinflammatory re-
sponse, exacerbates severe pulmonary tularemia-like disease in mice.
Results
NKT deficient CD1d-/- mice are less susceptible to i.n. LVS infection
IFN-γ is critically required for murine resistance to primary F. tularensis LVS infection. The
early production of IFN-γ after pulmonary LVS infection is primarily attributed to NK cells
and double negative T cells [26]. NKT cells are also a source of early IFN-γ and hence, we rea-
soned that they might contribute to resistance to i.n. LVS infection. We therefore investigated
whether NKT cell deficiency would alter disease outcome. Studies of immune function in infec-
tious disease rely on one of two methods—genetic deletion or in vivo depletion—by which to
assess their contribution to resistance or pathology. Because no unique NKT cell-specific mark-
er has been identified, the available Ab-mediated depletion methods deplete both NK and
NKT cells as these two cell types have significant overlap in surface marker expression, making
interpretation difficult. Mice made genetically deficient in NKT cells are therefore a better ex-
perimental model and were generated previously either by deletion of one of the TCR α-chain
gene segments (Jα18-/-) or by mutation of the restriction element required for thymic NKT cell
selection and antigen presentation in peripheral tissues (CD1d-/-) [27–30].
To determine how NKT cell deficiency affects the outcome of pulmonary F. tularensis infec-
tion, we first determined the LD50 to i.n. inoculation of the live vaccine strain (LVS) in C57BL/
6 (B6) mice using an established method [31,32]. During our preliminary experiments, we
found that infected mice lost up to 30% of their initial weight beginning d4 p.i.. Although
weight loss was observed at all doses tested (500, 2,000, 8,000 and 30,000 cfu), the degree of dis-
ease severity was dependent on the initial inoculum dose. It was only at a dose of 8,000 CFU
where we consistently observed moribund mice. At lower doses the majority of mice recovered
quickly with few outward signs of disease beyond slightly ruffled fur, which was not consistent
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between animals. Even at the higher dose, those WT mice that did not succumb by day 12
quickly began to regain weight and appeared otherwise healthy (S1 Fig). Other clinical mani-
festations included ruffled fur, hunched posture, labored breathing, and reduced mobility. Be-
cause we found that weight loss alone was not always an accurate predictor of disease severity,
a clinical score based on physical appearance was also included in our endpoint criteria (see
Materials and Methods). The resulting LD50 for i.n. LVS infection in B6 mice was ~6,000–
8,000 cfu (S1 Fig), which was consistent with that previously published by others [33–35].
To examine the contribution of NKT cells in resistance to primary pneumonic tularemia,
we first tested Jα18-/- mice. Hence, B6 and Jα18-/- mice were inoculated i.n. with ~8,000 cfu
LVS and monitored for weight loss and signs of morbidity as described in Materials and Meth-
ods. When compared to B6, Jα18-/- mice showed a significant increase in susceptibility to i.n.
LVS infection (Fig 1A), initially suggesting a protective role for iNKT cells. Although Jα18-/-
Fig 1. CD1d-/- mice are less susceptible to i.n. LVS infection. (A) Survival of B6 or Jα18-/- mice after i.n.
LVS infection. Survival of Jα18-/- andWTmice after intranasal LVS infection (8000 cfu). Curves were
compared using Log-rank (Mantel-Cox) Test. Data are from one of three similar experiments with at least 10
mice/group. (B) B6 or CD1d-/- mice were infected i.n. with LVS and monitored daily for weight loss. The mean
(±SD) weight of 50 animals/group in several independent experiments following intranasal infection
(Accumulation of five independent experiments with 10 mice/group in each experiment) is presented. (C)
Clinical score at various time points p.i. as determined in Materials and Methods. Data are cumulative from
four similar experiments (mean+SD) with 5–10 mice/group/time point. Data were analyzed as indicated in
Materials and Methods. (D) Survival of B6 or CD1d-/- mice after i.n. LVS infection. Cumulative survival curves
from 4 experiments with 40 mice/group. Curves were compared using Log-rank (Mantel-Cox) Test.
**p<0.01, ***p<0.001.
doi:10.1371/journal.ppat.1004975.g001
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mice have historically been used as a model for type I NKT cell deficiency, a recent study dem-
onstrated that they also have a profound defect in conventional αβ T cells, with the loss of an
estimated 60% of total TCRα repertoire diversity [36]. This report suggests that the increased
susceptibility observed in these mice might be due to this more global T cell deficiency rather
than the loss of iNKT cells, since conventional T cells were previously shown to mediate pro-
tective immunity to LVS [26,34].
We therefore ascertained the outcome of pulmonary LVS infection in CD1d-/- mice, which
have a normal complement of αβ T cells but lack NKT cells. By d4 post-inoculation (p.i.), both
B6 and CD1d-/- mice began to show signs of disease, including weight loss and ruffled fur. By
d5-6, B6 mice continued to lose more weight and showed more severe outward signs of disease
as indicated by clinical score (Fig 1B and 1C). In striking contrast, by d7, nearly all NKT defi-
cient CD1d-/- mice began to recover and a significantly lower percentage of CD1d-/- mice suc-
cumbed to i.n. LVS infection (Fig 1D). By d14, fewer than 50% B6 and almost all CD1d-/- mice
regained weight and showed no outward signs of disease, surviving the infection (Fig 1D).
These data suggest that NKT cells serve a deleterious role in pneumonic tularemia. We there-
fore reasoned that increased iNKT cell number might further exacerbate disease. Thus, Vα14tg
mice, which have increased numbers of iNKT cells [37], were infected intranasally and found
to have increased susceptibility as predicted (S2 Fig). Taken together, these data strongly sup-
port a detrimental function of NKT cells in pneumonic tularemia and show that CD1d-/- mice
are better model than Jα18-/- mice to study the role of NKT cells in disease. Hence, CD1d-/-
mice were used for all subsequent experiments.
Intranasal LVS infection recruits NKT cells to the lung interstitium
NKT cells are overrepresented among T cells in the healthy lung compared to their frequency
in other organs. These tissue-resident NKT cells do not recirculate but rapidly extravasate into
interstitial spaces upon recognition of lipid antigens such as the potent CD1d-restricted agonist
α-galactosylceramide (αGC) [1,38]. Whether NKT cells behave similarly in response to bacteri-
al infection, where lipid ligands are presumably of lower affinity [4], is unknown. To visualize
the location of NKT cells in naïve lungs, we injected B6 mice with anti-CD45 antibody (αCD45
Ab) i.v., allowed it to circulate through blood for several minutes, and tracked the anatomic lo-
calization of lung mononuclear cells by flow cytometry after labeling lung leukocytes with Abs
against lineage-specific markers. This quick procedure allows circulating αCD45 Ab to label all
intravascular cells (αCD45POS), while cells that are in the tissue interstitial space would be
αCD45NEG. We confirmed that the largest percentage of lymphocytes (T, B, and NK cells) was
in the αCD45POS intravascular population as reported previously [39]. Interestingly, we found
that a proportionately higher frequency of pulmonary NKT cells were present in the intersti-
tium (αCD45NEG) when compared to other lymphocytes (Fig 2A and S3 Fig). Such localization
suggests that pulmonary NKT cells occupy a frontline niche that allows them to rapidly sense
and respond to inhaled antigens.
To test the hypothesis that pulmonary NKT cells rapidly engage in host defense at frontline
niches, we inoculated B6 mice i.n. with ~LD50 of LVS. On d3 p.i., we injected αCD45 Ab and,
after several minutes, lungs were analyzed by flow cytometry for NKT cell localization. We
found a significant increase in the frequency of αCD45NEG interstitial NKT cells that was
equivalent to the frequency observed after i.n. αGC treatment (Fig 2B and S3 Fig). Further-
more, beginning d3 after i.n. LVS inoculation, we found a significant decrease in the frequency
of NKT cells in the blood when compared to uninfected controls (Fig 2C and S3 Fig). This re-
duction in circulating NKT cells was coincident with their increased numbers in the lungs (Fig
2C and 2D), more specifically and significantly in the lung interstitium (αCD45NEG lung
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NKT). Thus, i.n. LVS infection rapidly recruits NKT cells from the vasculature into the infected
lung interstitium. This finding is consistent with a previous report showing NKT cell extravasa-
tion into the lung interstitium after respiratory αGC administration [1].
A putative LVS-derived antigen activates lung-resident NKT cells
through the T cell receptor
NKT cells can be activated by recognition of CD1d-bound microbial lipids or self-lipids pre-
sented by activated APCs, or by cytokines which can activate these cells independent of TCR
stimulation [4]. The mechanism by which NKT cells are activated can influence their function.
To determine whether the accumulating NKT cells were activated by LVS infection, we moni-
tored expression of the activation marker CD69 which reports on NKT activation in general,
and we employed Nur77gfp reporter mice, which increase GFP expression only upon NKT cell
activation via CD1d-restricted microbial glycolipids but not self-lipids [40]. On d3 post i.n.
LVS inoculation, we found that both interstitial and intravascular NKT cells increased CD69
expression (Fig 3A). Strikingly, however, only the interstitial population showed increased GFP
Fig 2. NKT cells are recruited to the lung interstitium in response to LVS infection. (A) Intravascular αCD45 Ab staining to determine relative
distribution of the indicated lymphocytes in naïve lungs. Data combined from four similar experiments. Bars are mean+SD (n = 13 mice). Interstitial NKT cell
frequency was compared to all other lymphocyte populations as described in Materials and Methods. (B) Frequency of lung NKT cells among B220- cells
after i.n. αGC treatment or LVS inoculation. Mean+SD from one of two similar experiments (n = 3–4 mice/group). Frequency of interstitial NKT cells was
compared by one-way ANOVA with Tukey’s posttest. (C) Frequency of NKT cells in peripheral blood of LVS-infected or mock-infected mice. Mean±SD from
one of two similar experiments (n = 3–4 mice/group). Comparison was made by two-way ANOVA with Bonferroni posttest. (D) NKT cell number in total lung
or lung interstitium after i.n. LVS infection. Mean+SD combined from two similar experiments (n = 7 mice/ time point). Day 3 and day 5 post inoculation were
compared to naïve mice as described in Materials and Methods. *p<0.05, **p<0.01, ***p<0.001.
doi:10.1371/journal.ppat.1004975.g002
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fluorescence (Fig 3A). This result indicated that local LVS antigen presentation occurred within
the interstitium to activate LVS-recruited NKT cells in situ.
To determine the consequence of interstitial NKT cell activation, intracellular cytokine
staining was conducted directly ex vivo without any restimulation. We found that the GFPhi in-
terstitial NKT cells but not GFPlo intravascular cells produced IFN-γ (Fig 3A and 3B), demon-
strating that this cytokine production was a result of LVS infection in vivo. Taken together,
these data suggest that upon i.n. F. tularensis LVS infection, NKT cells migrate from the pe-
riphery and accumulate within the infected lung where they are activated through their TCR to
produce IFN-γ.
Modestly lower bacterial burden correlates with better clinical score in
CD1d-/- mice upon pulmonary LVS infection
Two factors can affect overall fitness after infection: pathogen burden and the level of organ pa-
thology. To determine whether the decreased susceptibility of CD1d-/- mice to LVS was due to
differences in bacterial burden, we measured LVS burden in lung homogenates at various time
points post i.n. LVS inoculation. Lung burden was similar in both groups, with a modest but
statistically significant difference (two-fold) seen only at d7 and d9 in infected CD1d-/- mice
(Fig 4A), which was concomitant with the observed differences in clinical score and weight loss
(Fig 1B and 1C).
Since the observed differences in illness began to appear at d7 p.i., we focused on this time
point for subsequent analyses. Differing degrees of lung pathology can result in different ani-
mal fitness despite similar bacterial burden [35,41,42]. To determine whether the difference in
morbidity was due to differential lung damage, we measured blood oxygen saturation (SpO2),
which was suggested as an accurate measure of lung pathology [43]. While both groups of mice
showed decreased SpO2 levels, there were no significant differences observed between groups
(Fig 4B). To more directly assess tissue damage, H&E-stained lungs were evaluated at d7 and
d9 p.i. As predicted by pulse oximetry data, the findings in the lungs of B6 and CD1d-/- mice
were similar. Lungs from both groups of mice displayed focally extensive interstitial
Fig 3. NKT cell activation by LVS is TCR-dependent. (A) Representative plots of NKT cell localization, activation, and IFN-γ production after i.n. LVS
infection of Nur77gfp mice. Numbers in contour plots are % NKT cells. Numbers in histograms are median fluorescence of infected mice (open histograms)
and mock-infected controls (shaded histograms). Data are representative of three similar experiments (n = 10). (B) Percent IFN-γ+ NKT cells in each
compartment after LVS infection. Bars are mean+SD. Data are representative from one of three similar experiments (n = 3 mice). Comparison was made by
one-way ANOVAwith Tukey’s posttest. ***p<0.001.
doi:10.1371/journal.ppat.1004975.g003
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Fig 4. CD1d-/- mice havemodestly reduced lung LVS burden but no differences in lung pathology. (A)
Lung burden was determined at various times p.i. as described in Materials and Methods. Data are combined
from at least 3 separate experiments. Bars are mean+SD of 10–15 mice/group/time point. (B)Oxygen
saturation was measured as described in Materials and Methods. Data are cumulative of 3 separate
experiments with 5–10 mice/group (mean±SD). (C) H&E stained formalin fixed paraffin embedded (FFPE)
lung sections d9 p.i. 40X (top) or 400X (bottom) magnification with scale bars as indicated. Data are
representative of three mice per group. Arrows indicate aggregations of lymphocytes. Data were analyzed as
indicated in Materials and Methods. **p<0.01, ***p<0.001.
doi:10.1371/journal.ppat.1004975.g004
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pneumonia with perivascular cuffs of mononuclear cells. Inflammatory infiltrate consisting of
macrophages and neutrophils filled the alveoli, which also contained necrotic debris and
edema with focal areas of necrosis on the alveolar walls (Fig 4C).
After i.n. infection, F. tularensis rapidly disseminates to the periphery [44]. The kinetics and
extent of dissemination are suggested as determinants of disease severity [45–48]. Hence, we
measured burden in blood, liver, and spleen. LVS was only transiently detectable in the blood,
where levels peaked at d3 p.i., but there were no differences in bacteremia between groups (Fig
5A). Liver burden was similar in both groups, but CD1d-/- mice had significantly lower splenic
burden d3–7 p.i. (Fig 5A). Further analysis showed that only lung burden—but not liver or
spleen—correlated with weight loss at d7 p.i. (S4 Fig). Consistent with these findings, histo-
pathological analysis failed to identify any striking differences in either liver or spleen patholo-
gy after intranasal inoculation (Fig 5B). The extent of hepatic granuloma formation did not
differ between groups (Fig 5B). Contrary to previous reports in BALB/c mice [49,50], splenic
architecture was mostly intact with some evidence of apoptosis and extramedullary hematopoi-
esis that did not seem to differ between groups (Fig 5B).
In summary, the above data indicate that the modest differences in bacterial burden in the
lungs and peripheral organs, or another mechanism, but not differential pulmonary, hepatic,
or splenic histopathology could explain the milder disease observed in NKT cell deficient mice.
Increased lymphocyte infiltrates organize into tertiary lymphoid
structures in CD1d-/- lungs in response to LVS infection
The differences described thus far become most pronounced at d7 p.i, suggesting that the quali-
ty of the adaptive response may be the principal underlying cause of the reduced susceptibility
observed in CD1d-/- mice. We therefore analyzed lymphocyte numbers in the lungs after LVS
infection. Lungs of CD1d-/- mice had consistently higher numbers of both B and T lympho-
cytes present at d7 p.i. (Fig 6A). To directly visualize the localization of these cells—whether
the lymphocytic infiltration was in the pulmonary vasculature or had extravasated into the
lung tissue—fixed frozen sections of infected lung were stained and examined by confocal mi-
croscopy. Consistent with earlier analysis of H&E stained sections, both groups of mice showed
extensive perivascular and peribronchiolar infiltration of leukocytes. Significantly however, in
addition to an increased cellularity in CD1d-/- mice, there was a striking difference in the de-
gree of organization of the infiltrating immune cells. We found evidence for the formation of
tertiary lymphoid structures, iBALT, within the infected lungs of CD1d-/- mice (Fig 6B). These
structures were marked by the formation of B cell follicles, which were surrounded by T cell
congregates. In contrast, fewer iBALT structures were formed in B6 mice by d7 p.i. (Fig 6C)
and those that developed were small and appeared rudimentary in that T and B cells were scat-
tered or at best loosely packed together (S5 Fig). Such tertiary lymphoid structures were not ob-
served in uninfected CD1d-/- or B6 mouse lungs (S6 Fig) suggesting that iBALTs formed in
response to pulmonary LVS infection.
Dendritic cells (DCs) are both necessary and sufficient for the induction of iBALT within
the lungs [51]. Consistent with previous reports, concentrations of CD11c+ cells were also ob-
served in and around the B and T cell zones of iBALT formed in CD1d-/- lungs (Fig 6B). Fur-
ther characterization of CD11c+ cells within the infected lungs by flow cytometry revealed that
all DC subsets identified were increased in the LVS infected lungs of CD1d-/- mice (Fig 6D).
Considering that DCs have been implicated as a primary vehicle for dissemination of F. tular-
ensis from the infected lung [45], this finding may also partially explain the reduced splenic
burden in CD1d-/- mice. Hence, iBALT formation in response to LVS infection of the lungs is
associated with milder tularemia-like disease in mice and prognosticates recovery.
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Decreased neutrophilia in CD1d-/- mice after LVS infection
A previous study showed that increased disease severity in a murine tularemia model was asso-
ciated with hepatic damage and neutrophilia [52]. NKT cells activated by LVS could cause liver
damage through direct lysis of infected hepatocytes [53,54]. They might also promote neutro-
philia through production of granulocyte colony-stimulating factor (G-CSF), the major neutro-
phil survival and proliferation factor [55]. Thus we monitored these two disease parameters in
Fig 5. CD1d-/- mice have reduced splenic LVS burden but no difference in the liver. (A) Blood, liver, and spleen burden were determined as in Fig 4.
Data are combined from 3 separate experiments. Bars are mean+SD of 6–10 mice/group/time point. Data were analyzed as indicated in Materials and
Methods. **p<0.01. (B) H&E stained FFPE liver (top) and spleen (bottom) sections d9 p.i., 200Xmagnification. Data are representative of 3 mice/group.
Arrows indicate granulomas.
doi:10.1371/journal.ppat.1004975.g005
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Fig 6. Formation of iBALT in CD1d-/- mice after i.n. LVS infection. (A)Groups of B6 or CD1d-/- mice were
infected i.n. with LVS. On d7 p.i., lungs were analyzed by flow cytometry for the indicated cell populations.
Data are cumulative of 2 experiments with 9–10 mice/group. Bars are mean+SD; compared as indicated in
Materials and Methods. (B) Representative images from F. tularensis LVS-infected lungs d7 p.i. Images are
individual mice from 2 of 3 similar experiments. 20X magnification; bars are 80 μm. Dashed lines indicate
large airways as identified by autofluorescence of epithelial cells. Arrows indicate rudimentary iBALT
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CD1d-/- mice. Although histological analysis failed to reveal any gross differences in liver pa-
thology (Fig 5B), we measured AST and ALT in the serum of infected animals as a more sensi-
tive indicator of hepatic injury (Fig 7A). CD1d-/- mice had serum ALT levels that were slightly,
yet significantly, lower than those measured in B6 mice, which implied slightly more severe
liver damage in the latter strain. However, when taken together with the absence of widespread
necrosis, these mild-to-moderate elevations in circulating hepatic enzymes are not consistent
with death from liver failure, particularly considering the similar liver burden in the two groups
of mice (Fig 5). Such slightly elevated ALT levels need not be a result of the death of infected
hepatocytes, but might rather be indicative of increased systemic inflammation [56].
To monitor the numbers of circulating neutrophils we performed complete blood counts
(CBC) at various time points post inoculation. B6 mice did indeed show more pronounced
neutrophilia d7 p.i. when compared to CD1d-/- mice (Fig 7B). This difference was not observed
in naïve mice and did not appear until d7 p.i. (Fig 7C). We found lower G-CSF levels in the
serum but not the lungs of CD1d-/- mice by d7 (Fig 7D), which was consistent with the lower
frequency of neutrophils in the blood (Fig 7B). Thus, decreased neutrophilia incited by LVS in-
fection in CD1d-/- mice could be one cause for their increased resistance to tularemia.
Tempered inflammatory response in CD1d-/- mice after LVS infection
Although IFN-γ is necessary for resistance to LVS, excessive production of proinflammatory
cytokines can be detrimental, particularly after intranasal infection [24,41]. Because NKT cells
are known to induce IFN-γ production by NK cells [57,58], we therefore asked whether
CD1d-/- mice—which have normal numbers of NK cells—might produce less IFN-γ in re-
sponse to LVS. We found that although the early IFN-γ response was comparable in both
groups of mice (S7 Fig), by d7 p.i. CD1d-/- mice had significantly lower levels in both the serum
and lung (Fig 8A and 8B).
Many cytokines produced by NKT cells were suggested to promote sepsis-like inflammatory
disease [11,59] and, hence, we measured the levels of those cytokines previously shown to be
induced by LVS infection that have also been associated with severe sepsis [49,60]. We found
that CD1d-/- mice had consistently lower levels of IFN-γ, IL-6, and TNF-α in both the lungs
and serum, with lower levels of MCP-1 and KC in the serum at d7 p.i. (Fig 8A and 8B) which
coincided with modestly reduced burden, reduced weight loss, and less severe outward signs of
disease (Fig 1). Hence, NKT deficiency results in a less severe “cytokine storm” in response to i.
n. LVS infection.
Given the observed differences in susceptibility among various mouse strains [61–64], we
next ascertained whether CD1d-/- mice in the BALB/c background would exhibit the same phe-
notype. Consistent with the results in C57BL6 background, we found that CD1d-/- mice were
less susceptible to LVS infection in the BALB/c background as well (Fig 9A). As observed with
C57BL6 mice, higher doses caused severe disease in both groups, although death was slightly
delayed in CD1d-deficient mice.
Mice are highly susceptible to several subspecies of Francisella and the extreme virulence of
type A (subspecies tularensis) or B (subspecies holarctica) strains complicates the study of ef-
fective immune responses, particularly when administered intranasally (LD50<10) [26].
formation in B6 lung and well-developed iBALT in lungs of CD1d-/-mice. (C) Enumeration of iBALT from d7
infected lung sections. Data are cumulative from three experiments (n = 6 mice/group). Bars are mean+SD.
Data were compared using MannWhitney U test. (D) DC subsets in infected lungs were identified as
described in Experimental Procedures. Representative results from 1 of 3 similar experiments (n = 5 mice/
group). Bars are mean+SD; MannWhitney U test. *p<0.05, **p<0.01, ***p<0.001.
doi:10.1371/journal.ppat.1004975.g006
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Although LVS has long been used in murine models of experimental tularemia [31,65], it is an
attenuated type B strain that fails to cause disease in humans. We therefore sought to determine
whether CD1d-/- would have a similar resistance to the more virulent type A strain Schu S4.
Not surprisingly however, both wild-type and CD1d-/- mice were extremely susceptible to a
low-dose (<10 CFU) pulmonary infection with Schu S4 (Fig 9B), similar to the results obtained
with higher doses of LVS in both C57BL6 (S1 Fig) and BALB/c (Fig 9A) mice. These data are
consistent with previous reports showing reduced efficacy of therapies or mutations that confer
resistance to LVS when challenged with Schu S4 [35,66–68].
Discussion
Once infected, the host has two strategies to deal with invasive pathogens: resistance and toler-
ance. Resistance implies the ability of the host to clear a pathogen or limit its spread whilst tol-
erance indicates the ability of the host to bear the ensuing pathology [69]. Surviving infection
Fig 7. CD1d-/- mice have less severe neutrophilia after intranasal LVS infection. (A) AST and ALT levels
were measured in serum of infected mice on d7 p.i. Data are combined from 3 experiments (n = 10–12).
Mean+SD. Shaded regions denote reference range. (B) CBC analysis of blood from LVS-infected mice
performed on d7. Data are combined from 2 separate experiments (n = 15 mice/group). Bars are mean+SD.
(C) Percent neutrophils in blood at the indicated time points p.i. Data are combined from 2 separate
experiments. Bars are mean+SD of 5–15 mice/group/time point. (D)On d7 serum and lung G-CSF levels
were measured by CBA. Data are combined from 2 experiments (n = 15 mice/group). Bars are mean+SD.
Comparisons were made as indicated in Materials and Methods. *p<0.05, ***p<0.001.
doi:10.1371/journal.ppat.1004975.g007
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from a pathogen such as F. tularensis likely requires a balance of both. Previous studies of infec-
tion in immunodeficient mice revealed that immunity to F. tularensis is mediated by the con-
certed effort of the innate and adaptive humoral and cellular immune responses. Because the
host deploys a wide array of effector mediators in its inflammatory arsenal against the infection
a sepsis-like disease ensues [22,26]. Hence, fatalities in this infectious disease appear to be
caused by an inability to control bacterial growth and dissemination, which precipitates inflam-
mation and causes irreparable collateral tissue damage. Accordingly, if diagnosed early, antibi-
otic treatment limits bacterial burden and tempers inflammation thereby controlling
morbidity and mortality underlying tularemia. Herein we report that NKT cells respond to in-
tranasal infection by migrating to the infected lung to produce IFN-γ, which promotes clear-
ance and killing of the pathogen. As a trade-off however, the early activation of NKT cells
causes excessive systemic inflammation, increases neutrophil mobilization, and delays infiltra-
tion of lymphocytes into the lungs and formation of protective tertiary lymphoid structures.
Hence, CD1d-deficient animals have a tempered inflammatory response and perform clinically
better in response to intranasal LVS infection. This advantage, however, can be overcome with
higher doses of bacteria or infection with more virulent subspecies. The discordant results ob-
tained using Jα18-/- and CD1d-/- mouse models likely reflect a more global T cell deficiency in
Jα18-/- mice and underscore the difficulties in deciphering the role of NKT cells using currently
available methods [14].
Fig 8. CD1d-/- mice exhibit a tempered inflammatory response to LVS. Cytokine levels were measured at 7d p.i. in lung homogenates (A) or serum (B) by
CBA. Data are combined from at least 3 experiments with 10–20 mice/group. Bars are mean+SD. Comparisons in these experiments were made as
indicated in Materials and Methods. *p<0.05, **p<0.01, ***p<0.001.
doi:10.1371/journal.ppat.1004975.g008
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Akin to CD1d-deficient animals, F. tularensis infection of metalloproteinase-9 null as well
as IL-17 and IL-10 double-deficient mice showed low disease incidence despite similar bacterial
burden [35,41]. In conjunction with a tempered inflammatory response, these immunode-
ficient mice were able to limit the damage caused by the pathogen or the host immune system
and were therefore less susceptible to i.n. F. tularensis infection. These findings and our data re-
ported herein, thus enforce the notion that the host response to F. tularensis is a balance be-
tween resistance to pathogen and tolerance to pathology.
LVS infection of endothelial cells induces the transmigration of neutrophils into infected tis-
sues [70,71]. Rather than contributing to host defense, neutrophils may instead increase disease
severity. F. tularensis-infected neutrophils assume an extended proinflammatory phenotype,
which is thought to contribute to increased tissue destruction [72]. Because F. tularensis is able
Fig 9. Reduced susceptibility of CD1d-/- mice is not dependent on strain background. (A)Groups of
6–8 week-old BALB/c or CD1d-/- mice were infected intranasally with different doses of LVS as indicated and
monitored for survival (n = 8 mice/group) (B) BALB/c or CD1d-/- mice were infected intranasally with 6 cfu
Schu S4 and monitored for survival (n = 8 mice/group).
doi:10.1371/journal.ppat.1004975.g009
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to infect and replicate within neutrophils, these cells likely serve as a vehicle for dissemination
from the primary site of infection, which might contribute to the reduced peripheral burden
observed in CD1d-/- mice [15,73]. Direct interaction with NKT cells has been shown to influ-
ence the function of neutrophils [74] and to promote hematopoiesis in both humans and mice
[75]. NKT cell-neutrophil interactions were also recently shown to exacerbate polymicrobial
sepsis [59]. Although we found no differences in differential cell counts from peripheral blood
of naive wild-type and CD1d-/- mice, CD1d-/- mice displayed less severe neutrophilia upon
LVS infection. We also found that slightly decreased hepatotoxicity, reduced peripheral bur-
den, and less severe inflammation in NKT cell-deficient CD1d-/- mice corresponded with less
severe neutrophilia.
Our studies revealed that acute LVS infection of CD1d-/- mice resulted in increased lympho-
cytic infiltration in the lung interstitium when compared to B6 mice. The cellular infiltration
organized into iBALT at the peak of infection. Although typically associated with chronic in-
flammatory conditions, iBALT has been shown to form in the lung in response to viral infec-
tion [51]. However, the formation of such structures in response to acute bacterial infection is
less well-studied. In the context of pulmonary F. tularensis infection, lymphoid aggregates have
been described in wild-type mice that survived F. tularensis infection after>50d p.i. whilst
bone fide iBALTs were described only in LPS/rPorB vaccinated mice challenged with a high
dose of LVS [49,76]. The post-vaccination development of these structures in the lungs was as-
sociated with better survival upon i.n. challenge with LVS or the more virulent F. tularensis
subspp. tularensis [76,77]. Data from these studies suggest that the T and B cells found in
iBALT limit the spread of the bacteria from the lung thereby reducing immune-mediated dam-
age to peripheral organs. Contrary to the results of these studies with wild-type animals, our
data demonstrate the development of iBALT in the lungs of B6 mice is hampered perhaps by
the presence and activation of NKT cells as more robust iBALT formation is observed in
CD1d-/- mice during the peak of a primary LVS infection. Such early iBALT formation is sug-
gestive of a more vigorous and effective adaptive immune response resulting in reduced sys-
temic inflammation and therefore less severe disease. These findings suggest a suppressive/
regulatory role for pulmonary NKT cells. The regulatory function of NKT cells is just begin-
ning to be elucidated and much of what we know derives from studies utilizing model antigens
[7]. Thus, our findings provide a model in which to study the potentially detrimental functions
of iNKT cells in a natural infection.
In the context of intranasal LVS infection, the inability to form iBALT proves to be detri-
mental, but there may be cases where this outcome is desirable. For example, iBALT formation
has been associated with chronic inflammatory conditions such as asthma [78]. Therefore, the
discovery of an NKT cell-activating ligand(s) derived from F. tularensis that can prevent
iBALT formation might be of therapeutic benefit in such instances. Similarly, a better under-




All procedures on mice were performed by approval from the IACUC at Vanderbilt University
School of Medicine and at Albany Medical College. Anesthesia was performed using 1–5% iso-
flurane or 100 mg/kg and 10 mg/kg ketamine and xylazine, respectively. Euthanasia was per-
formed by CO2 overdose followed by cervical dislocation.
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Mice
C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor). CD1d-/- mice were
a gift from L Van Kaer (Vanderbilt University School of Medicine). Jα18-/- mice were gener-
ously provided by M Taniguchi (RIKEN Institute, Yokohama, Japan). Mice were bred and
maintained in the School of Medicine vivarium and provided with food and water ad libitum.
LVS infection was performed in an ABSL-2 facility. Vanderbilt’s IACUC approved the experi-
ments described here.
Bacterial infection
F. tularensis LVS was provided by S. Khader (Washington University, St. Louis, MO). Prepara-
tion of working stocks and CFU determination from infected tissue were performed as de-
scribed [31]. LD50 was determined by the method of Reed and Muench [32]. Male, 8–12-week
old mice were anesthetized by i.p. administration of a ketamine/xylazine mixture and ~8–
10x103 CFU LVS were administered i.n. in 50μL sterile PBS. Mice were monitored daily for
weight loss and signs of morbidity. Criteria for clinical score were developed based upon obser-
vation of mice from at least three separate experiments: 1) no outward signs of illness; 2) con-
sistently ruffled fur; 3) hunched back and altered gait; 4) reduced mobility/reaction to stimulus,
labored breathing, lethargy. Mice were humanely euthanized when weight loss exceeded
30 percent.
Experiments with Schu S4 were conducted with approval of the Albany Medical College
IACUC (protocols 15–04001 and 15–04002). Six-to-eight week old BALB/c and C.129-CD1d-/-
mice were inoculated i.n. with the indicated dose of Schu S4 as described above for LVS.
Cytokine measurements
Cytokines were measured in serum or lung homogenates using Cytokine Bead Array assay (BD
Biosciences). Right lobes of lung were homogenized using a Tissue Tearor (Biospec Products,
Inc.) in 1 mL sterile PBS containing a cocktail of protease inhibitors (Roche). Homogenates
were centrifuged and supernatants frozen at -80°C until analyzed.
Pulse Oximetry
SpO2 was measured using the PhysioSuite with MouseSTAT Pulse Oximeter (Kent Scientific
Corp.). Mice were anesthetized using 1.5% isoflurane for induction and maintenance. Sensor
was attached to the right hind foot according to the manufacturer’s instructions. Measurements
were recorded at 5-second intervals for at least 4 minutes and averaged.
Tissue processing
Spleen, liver, and lungs were processed as previously described [1,79]. Left lung lobes were
used for flow cytometry and microscopy and right lobes for CFU determination.
Flow cytometry
NKT cells were analyzed as described [79]. All data were acquired on an LSR II (BD Biosci-
ences) and analyzed with FlowJo software (FlowJo, LLC). Cell populations were identified as
follows: B cells (CD19+); T cells (CD3ε+); NK cells (CD3ε-NK1.1+); NKT cells (CD3ε+CD1d/
αGC tetramer+); DCs (CD45+CD64-CD24+MHCII+CD11c+). DC subsets were identified as
described [80]. CD1d monomers were provided by the NIH Tetramer Core Facility. Cell counts
were determined using AccuCheck counting beads (Invitrogen).
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Immunofluorescence and confocal microscopy
To analyze the formation of tertiary lymphoid follicles in the lungs following LVS infection, tis-
sues were fixed in PLP buffer (2% paraformaldehyde, 0.05 M phosphate buffer containing 0.1
M L-lysine, and 2 mg/ml NaIO4) overnight. Tissues were then dehydrated in 30% sucrose and
subsequently embedded in OCT media. Twenty micron frozen sections were preincubated
with Fc-block (anti-mouse CD16/32 Ab; Biolegend) diluted in PBS containing 2% goat serum
and fetal bovine serum (FBS). After incubation for 1 hour at room temperature, sections were
washed with PBS and stained with the following antibodies diluted in PBS containing 2% goat
serum and FBS for 1 hour at room temperature: anti-B220-Alexa-488 (Biolegend), anti-
CD3-allophycocyanin, anti-CD11c-phycoerythrin (Biolegend) and Fc-block. Sections were
washed with PBS and mounted using Immu-Mount (Thermo Fisher Scientific). Images were
acquired using a Zeiss 780 confocal microscope (Carl Zeiss). The imaging data were processed
and analyzed using the Imaris software (Bitplane; Oxford Instruments).
Statistical analysis
Statistical analyses of representative data were performed using GraphPad Prism version 5.02
for Windows, GraphPad Software, San Diego California USA (www.graphpad.com). Where in-
dicated in the figure legends, data were aggregated across several (from two to four) replicate
experiments. To address the clustered nature of the final datasets, we used a linear regression
analysis with cluster robust standard error estimation (an extension of Huber-White Sandwich
Estimator [81–83]), a method that accounts for intraclass correlation when determining statis-
tical significance of regression coefficients. In all reported regression analyses individual data
points were entered as the dependent variable, and replicate experiments were identified as the
clustering variable. Experimental group type (KO and WT) was entered as the independent
variable and was dummy coded for the analyses with “KO” group as the reference category. In
such case, the intercept reflects the mean of the reference group (= KO), and the slope reflects
the difference between the KO and the WT groups. We have reported herein the significance
of coefficients for slopes (differences between group means). Clinical score data was analyzed
using Generalized Estimating Equation (GEE) model based on Poisson regression. In the
model, clinical score was predicted by group type and day of assessment (dummy coded), and
their interaction. We report comparisons between groups at each time of assessment, which
were obtained by changing the reference category between days of assessment. All analyses
were carried out using R Project for Statistical Computing (http://www.r-project.org/).
Supporting Information
S1 Fig. (A) Groups of B6 mice were inoculated intranasally with increasing doses of LVS as
indicated and monitored daily for weight loss and signs of morbidity.Data are representa-
tive of two similar experiments with 5 mice/group. Plotted are mean ± SD. (B-D) Groups of B6
or CD1d-/- mice were inoculated intranasally with 5 x 102 (B), 2 x 103 (C), or 3 x 104 (D) cfu
LVS and monitored daily for signs of morbidity. Mice were humanely euthanized when weight
loss exceeded 30% or when showing obvious signs of distress. Data are representative of two or
three experiments with 8–10 mice/group.
(TIF)
S2 Fig. Increased NKT cell numbers exacerbates disease. Groups of WT or Vα14tg mice were
infected intranasally with 8000 cfu LVS and monitored daily for weight loss and signs of mor-
bidity (n = 6–9 mice/group). Results are representative from one of three similar experiments.
(TIF)
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S3 Fig. NKT cells are pre-positioned in the lung and recruited into the interstitium after i.
n. LVS inoculation. (A) Representative plots of lung lymphocyte localization in naïve B6 mice.
Cells were identified as described in Materials and Methods. Intravascular αCD45 staining was
used to discriminate intravascular (αCD45POS) and interstitial (αCD45NEG) cells. Numbers are
percent of each cell type within the respective gate. (B) Representative intravascular staining of
NKT cell localization d3 after intranasal administration of 2 μg αGalCer (top) or ~8,000 cfu
LVS (bottom). Numbers are percent of CD3ε+CD1d/αGalCer tetramer+ cells. (C) Representa-
tive NKT staining of blood from mock- or LVS-infected mice at various time points p.i. Num-
bers in plots are percent of B220- lymphocytes.
(TIF)
S4 Fig. Lung burden, but not liver or spleen, are correlated with weight loss after i.n. LVS
infection. LVS burden was determined from homogenized lung, liver, and spleen d7 p.i. Data
are cumulative from more than three experiments with n values as indicated. Spearman corre-
lation analysis showed that only lung burden was correlated with weight loss at the peak
of infection.
(TIF)
S5 Fig. Tertiary lymphoid structures are more prominent in lungs of NKT-deficient mice.
Representative sections from B6 (left) and CD1d-/- (right) mice d7 post i.n. inoculation (8,000
cfu LVS).
(TIF)
S6 Fig. iBALT is not observed in the lungs of naïve, uninfected mice. Representative images
of naïve lung sections from B6 (left) or CD1d-/- (right) mice.
(TIF)
S7 Fig. CD1d-/-mice have an early IFN-γ response that is comparable to B6 mice. Lung and
serum IFN-γ levels were determined in naïve mice or at various time points p.i. as in Fig 8.
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